Xbrane Biopharma AB (publ) (STO:XBRANE)
10.25
+0.10 (0.99%)
Jul 24, 2026, 5:08 PM CET
Xbrane Biopharma AB Employees
Xbrane Biopharma AB had 29 employees as of June 30, 2026. The number of employees increased by 3 or 11.54% compared to the same quarter last year.
Employees
29
Change
3
Growth
11.54%
Revenue / Employee
2.87M SEK
Profits / Employee
-2.59M SEK
Market Cap
209.14M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 29 | 3 | 11.54% |
| Mar 31, 2026 | 28 | -36 | -56.25% |
| Dec 31, 2025 | 29 | -36 | -55.38% |
| Sep 30, 2025 | 26 | -39 | -60.00% |
| Jun 30, 2025 | 26 | -45 | -63.38% |
| Mar 31, 2025 | 64 | -11 | -14.67% |
| Dec 31, 2024 | 65 | -28 | -30.11% |
| Sep 30, 2024 | 65 | -27 | -29.35% |
| Jun 30, 2024 | 71 | -22 | -23.66% |
| Mar 31, 2024 | 75 | -15 | -16.67% |
| Dec 31, 2023 | 93 | 14 | 17.72% |
| Sep 30, 2023 | 92 | 18 | 24.32% |
| Jun 30, 2023 | 93 | 23 | 32.86% |
| Mar 31, 2023 | 90 | 26 | 40.63% |
| Dec 31, 2022 | 79 | 21 | 36.21% |
| Sep 30, 2022 | 74 | 18 | 32.14% |
| Jun 30, 2022 | 70 | 10 | 16.67% |
| Mar 31, 2022 | 64 | 13 | 25.49% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Nanologica AB | 72 |
| Diamyd Medical AB | 44 |
| IRLAB Therapeutics AB | 31 |
| Biovica International AB | 25 |
| NextCell Pharma AB | 24 |
| Xintela AB | 11 |
| Isofol Medical AB | 6 |
| Simris Group AB (PUBL) | 5 |
Xbrane Biopharma AB News
- 7 days ago - Xbrane Biopharma AB Earnings Call Transcript: Q2 2026 - Transcripts
- 7 days ago - Xbrane Biopharma AB Quarterly report: Q2 2026 - Filings
- 7 days ago - Xbrane Biopharma AB Slides: Q2 2026 - Filings
- 2 months ago - Xbrane Biopharma AB Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Xbrane Biopharma AB Quarterly report: Q1 2026 - Filings
- 2 months ago - Xbrane Biopharma AB Slides: Q1 2026 - Filings
- 5 months ago - Xbrane Biopharma AB Earnings Call Transcript: Q4 2025 - Transcripts
- 5 months ago - Xbrane Biopharma AB Annual report: Q4 2025 - Filings